Medical Journals

Non-neuronal Nicotinic Alpha 7 Receptor, a New Endothelial Target for Revascularization.

Authors:
  • Li Xiao-Wei
  • Wang Hai

From: Department of Cardiovascular Pharmacology, Institute of Pharmacology and Toxicology, 27 Tai Ping Road, Beijing 100850, China.

Life sciences

  • Publish Date: Mar 2006
  • ISSN: 0024-3205
  • Volume: 78
  • Issue: 16
  • Pages: 1863-70
  • Medium: Print
  • Language: English
  • Citation (JAMA): Li Xiao-Wei, Wang Hai, et al. Non-neuronal Nicotinic Alpha 7 Receptor, a New Endothelial Target for Revascularization.. Life Sci. Mar 2006;78:1863-70

Abstract

Alpha 7 nicotinic acetylcholine receptor (alpha7 nAChR) is widely expressed in the central and peripheral nervous systems, and is also found in several non-neuronal tissues, such as endothelial cells (ECs), bronchial epithelial cells, skin keratinocytes and vascular smooth muscle cells. Recent evidence suggests that alpha7 nAChR is involved in angiogenesis. Here, we investigated the feasibility of alpha7 nAChR for revascularization in ischemic heart disease. RT-PCR and immunohistochemistry were used to examine the expression of alpha7 nAChR in human umbilical vein endothelial cell (HUVECs). The cellular function was examined using MTT, fluorescence confocal microscopy and angiogenesis assay in vitro. The capillary density in the rat model of myocardial infarction (MI) was investigated using immunohistochemistry. The results showed that alpha7 nAChR agonists choline increased the expression of alpha7 nAChR mRNA and protein, the intracellular Ca 2+ concentration, proliferation and tube formation of ECs. Reverse effects were observed by using alpha7 nAChR antagonist alpha-BTX. Furthermore, in the rat model of MI, alpha7 nAChR agonist enhanced the capillary density in ischemic tissues, whereas antagonist mecamylamine and alpha-BTX inhibited the effect. Our results suggest that alpha7 nAChR is involved in the regulation of cellular function in ECs, and capillary formation in MI, which are the important steps of angiogenesis. Therefore, alpha7 nAChR on ECs may be a new endothelium target for revascularization in therapeutic angiogenesis of ischemic heart disease.

Mesh Headings (Keywords): Animals, Bungarotoxins, Calcium, Cell Proliferation, Cells, Cultured, Endothelium, Vascular, Humans, Male, Mecamylamine, Myocardial Infarction, Neovascularization, Pathologic, Nicotinic Agonists, Nicotinic Antagonists, RNA, Messenger, Rats, Rats, Sprague-Dawley, Receptors, Nicotinic, Reverse Transcriptase Polymerase Chain Reaction, Umbilical Veins


Check for Full Text / PubMed Unique Identifier (PMID): 16280133


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.